Repare Therapeutics Inc.
RPTX
$1.42
$0.032.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.04M | -28.67M | -34.41M | -34.77M | 13.16M |
| Total Depreciation and Amortization | 1.19M | 454.00K | 478.00K | 488.00K | 501.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.00M | 4.66M | 4.53M | 5.42M | 5.77M |
| Change in Net Operating Assets | -4.28M | -3.77M | -1.14M | -1.65M | -7.50M |
| Cash from Operations | -29.13M | -27.32M | -30.54M | -30.51M | 11.93M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.79M | 31.59M | 31.08M | 7.12M | -20.32M |
| Cash from Investing | 28.79M | 31.59M | 31.08M | 7.12M | -20.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 79.00K | 1.00K | 166.00K | 0.00 | 375.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 79.00K | 1.00K | 166.00K | 0.00 | 375.00K |
| Foreign Exchange rate Adjustments | -- | -87.00K | 14.00K | -1.00K | -42.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -262.00K | 4.18M | 721.00K | -23.40M | -8.05M |